The Gross Margin of Sinphar Pharmaceutical Co Ltd (1734.TW) is 39.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 39.26% |
| 2023-12-31 | 36.83% |
| 2022-12-31 | 38.20% |
| 2021-12-31 | 36.52% |
| 2020-12-31 | 36.66% |
| 2019-12-31 | 39.29% |
| 2018-12-31 | 37.25% |
| 2017-12-31 | 37.97% |
| 2016-12-31 | 37.02% |
| 2015-12-31 | 35.93% |